The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

In a recent episode of the global health and wellness show Bloom, host Gayle Guyardo welcomed Dr. Bharti Shetye, MD, MFOMA, a ...

Moreno said he expects that Zepbound could be used in addition to PAP or as an alternate for people who are uncomfortable ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version between February and March 2025.

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Now, getting Zepbound for OSA should be an easier process ... Further, these potential benefits will take time. Weight loss occurs slowly and requires a commitment to lifestyle changes, whereas ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Consumers who take copies of the popular weight loss and ... the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro to treat diabetes ...

The FDA is currently reconsidering its decision to take Zepbound off its drug shortages list following a lawsuit from a trade association representing compounding pharmacies. Removing Zepbound ...

So, Zepbound is expected to take the lead in the obesity market if it hasn’t already done so.” Based on SURMOUNT-5 results released last month, Zepbound was more effective in promoting weight ...

and perhaps negotiations with national health services will also make it more cost-effective than Wegovy,” Alciati continued.